Researcher
Geert Leroux-Roels
- Keywords:applied immunology, influenza, Vaccinology
- Disciplines:Infectious diseases, Vaccinology, Virology, Applied immunology
Affiliations
- Department of Diagnostic Sciences (Department)
Member
From1 Oct 2018 → Today - Department of Clinical chemistry, microbiology and immunology (Department)
Responsible
From1 Oct 2013 → 30 Sep 2017 - Department of Clinical chemistry, microbiology and immunology (Department)
Member
From1 Oct 2013 → 30 Sep 2017 - Board of Governors/Executive Board (Administrative office)
Member
From1 Oct 2008 → 30 Sep 2014 - Department of Clinical chemistry, microbiology and immunology (Department)
Member
From1 Oct 1997 → 30 Sep 2018
Projects
1 - 2 of 2
- BIOVACSAFE – Biomarkers for enhanced vaccine safetyFrom1 Mar 2012 → 31 Aug 2018Funding: Other EU initiatives out of framework
- Transmission fo the hepatitis C virus: from understanding the mechanisms to clinical applicationsFrom1 Jan 2012 → 31 Oct 2018Funding: BOF - Concerted Research Project from 1994
Publications
1 - 10 of 89
- Double-blind, placebo-controlled, dose-escalating study evaluating the safety and immunogenicity of an epitope-specific chemically defined nanoparticle RSV vaccine(2023)
Authors: Isabel Leroux-Roels, Jacques Bruhwyler, Lilli Stergiou, Mark Sumeray, Cathy Maes, Paul-Henri Lambert, Geert Leroux-Roels
- Human immunity and susceptibility to influenza A(H3) viruses of avian, equine, and swine origin(2023)
Authors: Elien Vandoorn, Wojciech Stadejek, Isabel Leroux-Roels, Geert Leroux-Roels, Anna Parys, Kristien Van Reeth
Pages: 98 - 109 - Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4+ T cell immunity within the FLUCOP consortium(2022)
Authors: Sarah Begue, Gwenn Waerlop, Bruno Salaun, Michel Janssens, Duncan Bellamy, Rebecca Jane Cox, Richard Davies, Elena Gianchecchi, Donata Medaglini, Emanuele Montomoli, et al.
- Randomized, double-blind, reference-controlled, phase 2a study evaluating the immunogenicity and safety of OVX836, a nucleoprotein-based influenza vaccine(2022)
Authors: Isabel Leroux-Roels, Gwenn Waerlop, Jessika Tourneur, FIEN DE BOEVER, Catherine Maes, Jacques Bruhwyler, Delphine Guyon-Gellin, Philippe Moris, Judith Del Campo, Paul Willems, et al.
- Characterization of the cell-mediated immune response to TakedaU+2019s live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic setting(2022)
Authors: Vianney Tricou, Raphael Gottardo, Michael A. Egan, Frédéric Clement, Geert Leroux-Roels, Xavier Sáez-Llorens, Astrid Borkowski, Derek Wallace, Hansi J. Dean
Pages: 1143 - 1151 - Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium(2022)
Authors: Gwenn Waerlop, Geert Leroux-Roels, Teresa Lambe, Duncan Bellamy, Donata Medaglini, Elena Pettini, Rebecca Jane Cox, Mai-Chi Trieu, Richard Davies, Geir Bredholt, et al.
- The role of cell-mediated immunity against influenza and its implications for vaccine evaluation(2022)
Authors: Yorick Janssens, Gwenn Waerlop, Frédéric Clement, Geert Leroux-Roels, Isabel Leroux-Roels
- Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : a phase 1 randomized clinical trial(2021)
Authors: PG Kremsner, P Mann, A Kroidl, Isabel Leroux-Roels, C Schindler, JJ Gabor, M Schunk, Geert Leroux-Roels, JJ Bosch, R Fendel, et al.
Pages: 931 - 941 - Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT) : a randomised, double-blind, phase 3 trial(2021)
Authors: T Vesikari, JM Langley, N Segall, BJ Ward, C Cooper, G Poliquin, B Smith, S Gantt, JE McElhaney, M Dionne, et al.
Pages: 1271 - 1281 - Immunogenicity and safety of a 3-antigen hepatitis B vaccine vs a single-antigen hepatitis B vaccine : a phase 3 randomized clinical trial(2021)
Authors: T Vesikari, A Finn, P van Damme, Isabel Leroux-Roels, Geert Leroux-Roels, N Segall, A Toma, G Vallieres, R Aronson, D Reich, et al.